ArticleJapanese journal of ophthalmology2013

Two-year results of reduced-fluence photodynamic therapy combined with intravitreal ranibizumab for typical age-related macular degeneration and polypoidal choroidal vasculopathy.

Yusaku Yoshida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.